Clinical Report: Creation of an Enhanced Humanized Mouse Model for Sjögren’s Syndrome
Overview
This study presents a novel humanized murine model that replicates key immunopathological features of Sjögren’s syndrome (SS), facilitating the investigation of disease mechanisms and therapeutic strategies. The model demonstrated significant immune cell infiltration and response to metformin treatment, highlighting its potential utility in preclinical research.
Background
Sjögren’s syndrome is a systemic autoimmune disease that primarily affects exocrine glands, leading to significant morbidity due to symptoms like dry mouth and dry eyes. The complexity of SS necessitates the development of accurate preclinical models to better understand its pathogenesis and evaluate new therapies. Current animal models often fail to fully replicate the human disease, underscoring the need for improved models that incorporate human immune responses.
Data Highlights
Parameter
Findings
Human IL-17-producing T cells
Increased frequency in spleen
Salivary gland infiltration
Marked immune cell infiltration observed
Aquaporin-5 expression
Significantly reduced in SS-derived PBMC-injected mice
Metformin treatment
Attenuated salivary gland inflammation and reduced pathogenic T cell infiltration
Key Findings
The humanized murine model effectively reproduces key features of Sjögren’s syndrome.
Injection of PBMCs from SS patients led to increased IL-17-producing T cells in the spleen.
Significant immune cell infiltration was observed in the salivary glands of model mice.
Metformin treatment significantly reduced inflammation and tissue damage in the salivary glands.
The model provides a platform for evaluating novel therapeutic strategies for SS.
Clinical Implications
The development of this humanized mouse model offers a valuable tool for researchers to explore the underlying mechanisms of Sjögren’s syndrome and assess potential therapies. The observed effects of metformin suggest that existing medications may have a role in managing SS-related inflammation.
Conclusion
This study establishes a humanized mouse model that closely mimics the immunopathology of Sjögren’s syndrome, paving the way for future research into disease mechanisms and treatment options.
